During the past decade, Helene A. Emsellem MD PC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helene A. Emsellem MD PC" #1 sponsor was "Cephalon" with 3 trials, followed by "Harmony Biosciences, LLC" with 2 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored, "Millennium Pharmaceuticals, Inc." with 2 trials sponsored and "Avadel" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Helene A. Emsellem MD PC" are "Narcolepsy" (4 trials), "Idiopathic Hypersomnia" (3 trials), "Insomnia Disorder" (2 trials), "Sleep Apnea, Obstructive" (2 trials) and "Cataplexy" (1 trials). Many other conditions were trialed in "Helene A. Emsellem MD PC" in a lesser frequency.

Most popular intervention types in "Helene A. Emsellem MD PC" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Modafinil" (3 trials), "Daridorexant 25 mg" (2 trials), "Daridorexant 50 mg" (2 trials) and "TAK-925" (2 trials). Other intervention names were less common.

The vast majority of trials in "Helene A. Emsellem MD PC" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Helene A. Emsellem MD PC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Helene A. Emsellem MD PC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Helene A. Emsellem MD PC, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".